SCHERING-PLOUGH CAN ENTER GENERIC ALBUTEROL MDI MARKET "EXTREMELY FAST" THROUGH WARRICK SUBSIDIARY, FIRM TELLS ANALYSTS; PROVENTIL U.S. SALES AHEAD 30%
Executive Summary
Schering-Plough is prepared to enter the market for generic metered-dose inhaler versions of Proventil (albuterol) through its Warrick Pharmaceuticals subsidiary, the company indicated during a meeting with securities analysts June 30 in New York City.